Asia-Pacific Organ Preservation Market is segmented By Transportation Technique (Static Cold Storage (SCS), Hypothermic Perfusion Preservation (HPP), Normothermic Machine Perfusion, and Others) By Preservation Solution (University of Wisconsin Solution, Custodiol HTK, Perfadex, and Others) By Organ Type (Kidney, Liver, Lung, and Others), and By Region (India, China, Japan, South Korea, Australia, and Rest of Asia Pacific) – Share, Size, Outlook, and Opportunity Analysis, 2023-2030
Asia-Pacific Organ Preservation Market Overview
The Asia-Pacific Organ Preservation Market is expected to grow at a CAGR of 6.5% during the forecast period 2023-2030.
Organ transplantation entails removing an organ from a donor body, transferring the organ, and transplanting the organ into another body while protecting the organ from major harm. Although inducing hypothermia by lowering organ temperature may aid in preservation, distinct bodily organs need specific and suitable storage settings to sustain their anatomical and physiological activities.
The growing prevalence of organ failure, increased research and development, technological improvements, and rising chronic renal disease are the primary driving factors projected to fuel market growth.
Asia-Pacific Organ Preservation Market Summary and Scope
|
Metrics |
Details |
|
CAGR |
6.5% |
|
Size Available for Years |
2021-2030 |
|
Forecast Period |
2023-2030 |
|
Data Availability |
Value (US$) |
|
Segments Covered |
Transportation Technique, Preservation Solution, and Organ Type. |
|
Countries Covered |
India, China, Japan, South Korea, Australia, and Rest of Asia Pacific |
|
Report Insights Covered |
Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter’s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis and Other key Insights. |
For more details on this report Request for Sample
Asia-Pacific Organ Preservation Market Drivers
Increasing Multiple Organ Failures is Expected to Drive the Market Growth
The number of cases of organ failure caused by numerous health disorders, such as severe diabetes, is steadily growing around the globe. As a consequence, the number of organ transplants has skyrocketed. Consequently, the global demand for organ preservation has increased drastically. Despite a substantial supply-demand imbalance, various initiatives are being launched to encourage organ donation in order to fulfil the rising demand for organ transplants, which would likely help the development of the Asia Pacific organ preservation market during the projected period.
The Asia Pacific organ preservation market is expected to grow at a strong CAGR during the projected period due to significant breakthroughs in the area of organ transplantation and preservation. Advances in preserving methods and practices have also made organs more accessible in rural regions. Furthermore, as medical technology progresses, the success rates of organ transplants are growing, such that an increasing number of individuals are choosing such a transplant.
Asia-Pacific Organ Preservation Market Opportunities
Technological advancements, such as the usage of artificial intelligence and robotics, are providing lucrative opportunities for market growth.
Asia-Pacific Organ Preservation Market Segmentation Analysis
The Asia-Pacific Organ Preservation Market is segmented by transportation technique, preservation solution, and organ type.
Transportation Technique: The Static Cold Storage Segment is Expected to Grow at the Fastest CAGR During the Forecast Period
The static cold storage (SCS) segment has the largest market share in the Asia Pacific organ preservation market due to a rise in the number of organ failures, which has led to a growth in organ transplantation and research activities. Static cold storage involves the movement of donated organs on ice. For many decades, it has been the finest standard for the preservation of various organizations.
Static cold storage is based on hypothermia, which reduces the demand for oxygen as well as cellular metabolism, allowing for the preservation of organs to last longer. Cold storage reduces metabolic activity by around tenfold and promotes anaerobic metabolism, which interrupts the energy cycle. According to the nature journal article "Organ Preservation: From Past to Future," static cold storage is the most successful and easy method for organ preservation and transportation. This is the most prevalent strategy for organ preservation.
Asia Pacific Organ Preservation Market Regional Insights
By region the Asia Pacific organ preservation market is segmented into India, China, Japan, South Korea, Australia, and Rest of Asia Pacific.
The fastest growth in the Asia Pacific market is owing to the rising population, higher living standards, increased healthcare expenditure, and desire for new and innovative treatment alternatives.
China's growing geriatric population, advantageous reimbursement policies, and rising burdens of diabetes, cardiovascular disease, diabetic nephropathy, and obesity will all have a beneficial influence on market growth in the future years.
Japan is a world leader in the preservation of organs. As a result, it controls a significant portion of the Asia Pacific organ preservation business. For example, at the end of 2021, there were 32 transplant institutions with a successful track record of kidney transplantation. Pacific areas will also have robust development in the future years as a result of increased awareness and sophisticated healthcare facilities.
Asia-Pacific Organ Preservation Market Competitive Landscape
The major companies operating in the Asia Pacific organ preservation market are Essential Pharmaceuticals, Dr. Franz Kohler Chemie GmbH, Organ Recovery Systems, Xvivo Perfusion AB, and Waters Medical Systems LLC.
